Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Electrophysiology Lab Systems are used for the visualization, diagnosis and treatment of cardiac arrhythmias. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrophysiology lab systems market in Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the electrophysiology lab systems market in Japan was Abbott Laboratories followed by Biosense Webster, Boston Scientific, GE HealthCare Technologies, Koninklijke Philips, Medtronic, Micropace EP and Siemens Healthineers.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Different components are tracked in this segment, includes 3D Mapping Systems, EP Recording Systems, Intracardiac Echocardiography Systems, RF Ablation Generators, and Cardiac Stimulators. An advanced 3D mapping system allows electrophysiologists to navigate the heart and place catheters during an EP study. An Electrophysiology (EP) recording system allows electrophysiologists to record information on the electrical activity of the patient's heart during an EP study, including signals from surface and intracardiac electrograms, cardiac stimulators and other monitoring systems. The Intracardiac Echocardiography (ICE) system is an ultrasound console that utilizes echocardiography to provide real-time image and guidance of cardiac structures during EP procedures. RF Ablation Generators utilize radiofrequency energy for ablation procedures. A cardiac stimulator is a device that induces temporary cardiac pacing during an electrophysiology study.
The electrophysiology lab systems market in Japan can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size electrophysiology lab systems in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
